Please assess the completion status of the following clinical trial:

Trial Title: A Comparison of Serum and Urine N-telopeptide Marker

Study Design Characteristics:
- Allocation: None
- Intervention Model: None
- Observational Model: COHORT
- Primary Purpose: None
- Time Perspective: PROSPECTIVE
- Masking: None
- Phase: None
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~* Consent to participate in the study~* Participants limited to subjects in the CCF~* Age between and inclusive of 18 and 85 years of age~* No gender exclusion~* Patients diagnosed with Osteopenia on DEXA scan who have not been on any medical therapy in the past~* Presence of normal vitamin D levels, kidney function, and parathyroid hormone levels (per our reference ranges)~Exclusion Criteria:~* Prior history of medical therapy for osteopenia~* Prior radiation therapy~* Prior history of bone fracture~* History of high risk medication associated with increased risk of fracture~* Presence of abnormal vitamin D levels, kidney function, and parathyroid hormone~* Pregnancy status (verbal)~* Those with medical co-morbidities that increase the risk of fracture will be excluded and these include but are not limited to: rheumatoid arthritis, ankylosing spondylitis, psoriatic arthritis, diabetes mellitus, hyperparathyroidism, chronic kidney disease, pituitary disease, multiple myeloma, leukemia, lymphoma, thalassemia major, HIV/AIDS, malabsorption, Inflammatory bowel disease, chronic obstructive pulmonary disease, hypogonadism, chronic liver disease, untreated hyperthyroidism, and those with chronic immobility

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 85 Years
- Healthy Volunteers: f

Study Arms:
- Osteopenia, no past medical therapy (Type: None): Patients diagnosed with osteopenia on DEXA scan who have not been on any medical therapy in the past

Based on this trial design, predict the completion outcome and termination type (if applicable).